Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: Babson College
Originally published in: 2002
Version: 24 April 2002
Length: 15 pages
Data source: Published sources

Abstract

This case describes the corporate structure of US-based Merck during the period 1999-2000. Merck is the No 1 healthcare and pharmaceutical firm with global sales of $32.7billion. Operations are segmented into Merck Pharmaceutical (pharmaceuticals) and Merck-Medco, LLC (managed care). The case provides an overview of corporate governance, including a description of the executive committees, their roles and responsibilities, remuneration, and accountability/audit. One of two cases drawn from public information sources. May be used alone or with the case ''AstraZeneca PLC: Corporate Governance at a Pharmaceutical Company'' (302-061-1). Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and also corporate governance and corporate structure in the pharmaceutical industry.
Location:
Industry:
Size:
USD32.7 billion
Other setting(s):
2000

About

Abstract

This case describes the corporate structure of US-based Merck during the period 1999-2000. Merck is the No 1 healthcare and pharmaceutical firm with global sales of $32.7billion. Operations are segmented into Merck Pharmaceutical (pharmaceuticals) and Merck-Medco, LLC (managed care). The case provides an overview of corporate governance, including a description of the executive committees, their roles and responsibilities, remuneration, and accountability/audit. One of two cases drawn from public information sources. May be used alone or with the case ''AstraZeneca PLC: Corporate Governance at a Pharmaceutical Company'' (302-061-1). Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and also corporate governance and corporate structure in the pharmaceutical industry.

Settings

Location:
Industry:
Size:
USD32.7 billion
Other setting(s):
2000

Related